A detailed history of Penbrook Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Penbrook Management LLC holds 5,273 shares of ABBV stock, worth $925,833. This represents 0.72% of its overall portfolio holdings.

Number of Shares
5,273
Previous 5,373 1.86%
Holding current value
$925,833
Previous $921,000 13.03%
% of portfolio
0.72%
Previous 0.6%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $16,384 - $19,933
-100 Reduced 1.86%
5,273 $1.04 Million
Q1 2024

Apr 18, 2024

SELL
$159.82 - $182.1 $9,269 - $10,561
-58 Reduced 1.07%
5,373 $978,000
Q2 2023

Jul 17, 2023

SELL
$132.51 - $164.9 $39,753 - $49,470
-300 Reduced 5.23%
5,431 $731,000
Q4 2022

Jan 24, 2023

SELL
$138.31 - $165.87 $75,378 - $90,399
-545 Reduced 8.68%
5,731 $0
Q3 2022

Oct 31, 2022

BUY
$134.21 - $153.93 $3,489 - $4,002
26 Added 0.42%
6,276 $842,000
Q2 2022

Jul 29, 2022

SELL
$137.62 - $174.96 $139,271 - $177,059
-1,012 Reduced 13.94%
6,250 $957,000
Q2 2021

Jul 27, 2021

BUY
$105.21 - $117.21 $17,254 - $19,222
164 Added 2.31%
7,262 $818,000
Q1 2021

May 05, 2021

BUY
$102.3 - $112.62 $327,155 - $360,158
3,198 Added 82.0%
7,098 $768,000
Q1 2021

Apr 16, 2021

SELL
$102.3 - $112.62 $340,352 - $374,686
-3,327 Reduced 46.04%
3,900 $297,000
Q4 2020

Apr 25, 2022

SELL
$80.49 - $108.67 $127,737 - $172,459
-1,587 Reduced 18.01%
7,227 $774,000
Q4 2020

Jan 27, 2021

BUY
$80.49 - $108.67 $162,589 - $219,513
2,020 Added 29.73%
8,814 $944,000
Q2 2020

Jul 28, 2020

BUY
$73.37 - $98.18 $212,332 - $284,132
2,894 Added 74.21%
6,794 $667,000
Q1 2020

Apr 14, 2020

BUY
$64.5 - $97.79 $3,870 - $5,867
60 Added 1.56%
3,900 $297,000
Q4 2017

Feb 21, 2018

BUY
$89.56 - $98.21 $343,910 - $377,126
3,840
3,840 $371,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Penbrook Management LLC Portfolio

Follow Penbrook Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penbrook Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penbrook Management LLC with notifications on news.